TFGT
SRPT icon

TS Financial Group (TSFG)’s Sarepta Therapeutics SRPT Stock Holding History

TS Financial Group (TSFG)’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,260
Closed -$24K – 887
2025
Q3 		$24K Buy
+1,260
New +$22.5K ﹤0.01% 449
2024
Q4 		– Sell
-50
Closed -$6K – 818
2024
Q3 		$6K Sell
50
-75
-60% -$10.4K ﹤0.01% 576
2024
Q2 		$20K Sell
125
-35
-22% -$4.5K ﹤0.01% 378
2024
Q1 		$21K Hold
160
– – 0.01% 369
2023
Q4 		$15K Hold
160
– – ﹤0.01% 455
2023
Q3 		$19K Sell
160
-95
-37% -$10.7K 0.01% 419
2023
Q2 		$29K Hold
255
– – 0.01% 372
2023
Q1 		$35K Hold
255
– – 0.01% 325
2022
Q4 		$33K Hold
255
– – 0.01% 332
2022
Q3 		$28K Hold
255
– – 0.01% 351
2022
Q2 		$19K Hold
255
– – 0.01% 415
2022
Q1 		$20K Sell
255
-130
-34% -$9.96K 0.01% 427
2021
Q4 		$35K Sell
385
-30
-7% -$2.56K 0.01% 349
2021
Q3 		$38K Buy
415
+20
+5% +$1.54K 0.01% 352
2021
Q2 		$31K Sell
395
-1,045
-73% -$79.2K 0.01% 375
2021
Q1 		$107K Buy
1,440
+850
+144% +$78.4K 0.05% 163
2020
Q4 		$101K Sell
590
-35
-6% -$5.19K 0.05% 157
2020
Q3 		$88K Buy
625
+60
+11% +$9.12K 0.05% 152
2020
Q2 		$91K Sell
565
-285
-34% -$38.8K 0.06% 145
2020
Q1 		$83K Buy
850
+490
+136% +$56K 0.07% 136
2019
Q4 		$46K Sell
360
-105
-23% -$10.6K 0.03% 238
2019
Q3 		$35K Buy
465
+80
+21% +$9.45K 0.03% 257
2019
Q2 		$59K Sell
385
-75
-16% -$9.12K 0.05% 197
2019
Q1 		$55K Buy
+460
New +$59.1K 0.05% 196

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

TS Financial Group (TSFG)'s SRPT Position: Q4 2025 in Review

TS Financial Group (TSFG) sold out of Sarepta Therapeutics (SRPT) in Q4 2025, closing a stake of 1,260 shares — an estimated $24K sold.

TS Financial Group (TSFG) first reported a position in SRPT in Q1 2019 and held it in 24 quarters. The position peaked at $107K in Q1 2021. 345 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • TS Financial Group (TSFG) reported no remaining Sarepta Therapeutics position as of Q4 2025 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 1,260 Sarepta Therapeutics shares in Q4 2025, an estimated $24K.
  • TS Financial Group (TSFG) first reported a position in Sarepta Therapeutics in Q1 2019 and held it in 24 quarters.
  • TS Financial Group (TSFG)'s Sarepta Therapeutics position peaked at $107K in Q1 2021.
  • 345 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2025, filed 4 Feb 2026.